The Latin America, Middle East and Africa Pen Needles Market would witness market growth of 13.2% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 9,621.2 thousand Units, showcasing a growth of 15.2% (2023-2030).
A pen needle is a small, disposable medical device attached to the injector pen used to administer various medications. These needles come in different lengths and gauge sizes and are made of plastic or plastic-coated metal to make them easier to handle. The needle is made of stainless steel, which is strong and durable enough to pierce the skin with minimal discomfort. The tip of the needle is often slanted to aid in skin penetration, and a lubricant is applied to reduce injection pain.
Insulin pens coupled with needles are considered an improved alternative drug delivery process in comparison to syringes and vials. Traditional syringes are large and create difficulty in self-administration. However, these have fine pointed tips, which help easily penetrate the patient's muscles. These needles also facilitate the safety of insulin delivery amongst diabetic patients. In addition, technological advancements in pen needle manufacturing and safety features, an increase in investments by key players in the development of advanced pen needles, and the availability of pen needles through various distribution channels are contributing to the growth of the market.
The market in LAMEA reflects the ongoing efforts to address the needs of individuals with diabetes and other chronic conditions. As the region continues to experience changes in healthcare delivery, regulatory compliance, and patient empowerment, the demand for these needles is expected to remain strong. Manufacturers will likely continue to innovate and improve pen needle technology to meet the specific needs and preferences of patients in the LAMEA region, ensuring their comfort and safety during subcutaneous injections. The factors mentioned above will expand the market growth across the region in the coming years.
The Brazil market dominated the LAMEA Pen Needles Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $82.1 million by 2030. The Argentina market is experiencing a CAGR of 13.8% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 12.9% during (2023 - 2030).
Based on Type, the market is segmented into Standard Pen Needles, and Safety Pen Needles. Based on Setting, the market is segmented into Homecare, Hospitals & Clinics, and Others. Based on Application, the market is segmented into Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone, Osteoporosis, and Others. Based on Length, the market is segmented into 8mm, 6mm, 5mm, 10mm, 12mm, and 4mm. Based on Mode of Purchase, the market is segmented into Over the Counter, Prescription-based, Online Purchase, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Embecta Corp., Novo Nordisk A/S, Ypsomed AG, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Limited, Arkray, Inc., UltiMed, Inc. and Allison Medical, Inc.
A pen needle is a small, disposable medical device attached to the injector pen used to administer various medications. These needles come in different lengths and gauge sizes and are made of plastic or plastic-coated metal to make them easier to handle. The needle is made of stainless steel, which is strong and durable enough to pierce the skin with minimal discomfort. The tip of the needle is often slanted to aid in skin penetration, and a lubricant is applied to reduce injection pain.
Insulin pens coupled with needles are considered an improved alternative drug delivery process in comparison to syringes and vials. Traditional syringes are large and create difficulty in self-administration. However, these have fine pointed tips, which help easily penetrate the patient's muscles. These needles also facilitate the safety of insulin delivery amongst diabetic patients. In addition, technological advancements in pen needle manufacturing and safety features, an increase in investments by key players in the development of advanced pen needles, and the availability of pen needles through various distribution channels are contributing to the growth of the market.
The market in LAMEA reflects the ongoing efforts to address the needs of individuals with diabetes and other chronic conditions. As the region continues to experience changes in healthcare delivery, regulatory compliance, and patient empowerment, the demand for these needles is expected to remain strong. Manufacturers will likely continue to innovate and improve pen needle technology to meet the specific needs and preferences of patients in the LAMEA region, ensuring their comfort and safety during subcutaneous injections. The factors mentioned above will expand the market growth across the region in the coming years.
The Brazil market dominated the LAMEA Pen Needles Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $82.1 million by 2030. The Argentina market is experiencing a CAGR of 13.8% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 12.9% during (2023 - 2030).
Based on Type, the market is segmented into Standard Pen Needles, and Safety Pen Needles. Based on Setting, the market is segmented into Homecare, Hospitals & Clinics, and Others. Based on Application, the market is segmented into Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone, Osteoporosis, and Others. Based on Length, the market is segmented into 8mm, 6mm, 5mm, 10mm, 12mm, and 4mm. Based on Mode of Purchase, the market is segmented into Over the Counter, Prescription-based, Online Purchase, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Embecta Corp., Novo Nordisk A/S, Ypsomed AG, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Limited, Arkray, Inc., UltiMed, Inc. and Allison Medical, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)- Standard Pen Needles
- Safety Pen Needles
- Homecare
- Hospitals & Clinics
- Others
- Insulin
- Glucagon-like-Peptide-1 (GLP-1)
- Growth Hormone
- Osteoporosis
- Others
- 8mm
- 6mm
- 5mm
- 10mm
- 12mm
- 4mm
- Over the Counter
- Prescription-based
- Online Purchase
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Embecta Corp.
- Novo Nordisk A/S
- Ypsomed AG
- B.Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Owen Mumford Limited
- Arkray, Inc.
- UltiMed, Inc.
- Allison Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Pen Needles Market by Type
Chapter 6. LAMEA Pen Needles Market by Setting
Chapter 7. LAMEA Pen Needles Market by Application
Chapter 8. LAMEA Pen Needles Market by Length
Chapter 9. LAMEA Pen Needles Market by Mode of Purchase
Chapter 10. LAMEA Pen Needles Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Embecta Corp.
- Novo Nordisk A/S
- Ypsomed AG
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Owen Mumford Limited
- Arkray, Inc.
- UltiMed, Inc.
- Allison Medical, Inc.
Methodology
LOADING...
